Content continues after advertisement

Therapeutics Research Note: Fluralaner & Ivermectin

Clinician's Brief (Capsule)

Sign in to Print/View PDF

Fluralaner, a novel, systemic ectoparasiticide, provides dogs with immediate control of fleas and ticks and persists in the system for 12 weeks. Because of their potential concurrent use, this study analyzed pharmacokinetic profiles of fluralaner and ivermectin given alone and in conjunction. Neither drug’s pharmacokinetic profile was altered, and concurrent use did not increase the risk for ivermectin-associated neurotoxicity.


For global readers, a calculator to convert laboratory values, dosages, and other measurements to SI units can be found here.

All Clinician's Brief content is reviewed for accuracy at the time of publication. Previously published content may not reflect recent developments in research and practice.

Material from Clinician's Brief may not be reproduced, distributed, or used in whole or in part without prior permission of Educational Concepts, LLC. For questions or inquiries please contact us.


Clinician's Brief:
The Podcast
Listen as host Alyssa Watson, DVM, talks with the authors of your favorite Clinician’s Brief articles. Dig deeper and explore the conversations behind the content here.
Clinician's Brief provides relevant diagnostic and treatment information for small animal practitioners. It has been ranked the #1 most essential publication by small animal veterinarians for 9 years.*

*2007-2017 PERQ and Essential Media Studies

© 2023 Educational Concepts, L.L.C. dba Brief Media ™ All Rights Reserved. Terms & Conditions | DMCA Copyright | Privacy Policy | Acceptable Use Policy